Shenwei Pharmaceutical Industry(02877) according to the results for the six months ended June 30, 2021, the group achieved an income of 1.554 billion yuan (the same unit below), an increase of 30.58% over the same period last year; a profit of 308 million yuan during the period, an increase of 21.57% over the same period last year; and basic earnings per share of 41 points.
The increase in net profit was lower than that of sales and the decline in net profit margin was mainly due to a total decrease of 42.2% in investment income and other income in the first half of this year compared with the same period last year. Pre-tax operating profit for the first six months of 2021, excluding investment income, other income, financial costs and taxes, was 298.5 million yuan, up 74.4 percent from 171.15 million yuan in the same period last year.